Literature DB >> 23430498

Urinary neopterin and phenylalanine loading test as tools for the biochemical diagnosis of segawa disease.

Vincenzo Leuzzi1, Claudia Carducci, Flavia Chiarotti, Daniela D'Agnano, Maria Teresa Giannini, Italo Antonozzi, Carla Carducci.   

Abstract

Background. The diagnosis of autosomal dominant GTP-cyclohydrolase deficiency relies on the examination of the GCH1 gene and/or pterins and neurotransmitters in CSF. The aim of the study was to assess the diagnostic value, if any, of pterins in urine and blood phenylalanine (Phe) and tyrosine (Tyr) under oral Phe loading test. Methods. We report on two new pedigrees with four symptomatic and four asymptomatic carriers whose pattern of urinary pterins and blood Phe/Tyr ratio under oral Phe loading pointed to GTP-cyclohydrolase deficiency. The study was then extended to 3 further patients and 90 controls. The diagnostic specificity and sensitivity of these metabolic markers were analysed by backwards logistic analysis. Results. Two genetic alterations segregated alternatively in Family 1 (c.631-632 del AT and c.671A > G), while exon 1 deletion was transmitted along three generations in Family 2. Neopterin and biopterin concentrations in urine clustered differently in controls under and over the age of 15. Therefore patients and controls were sub grouped according to this age. Neopterin was significantly reduced in GCH1 mutated subjects younger than 15, and both neopterin and biopterin in those older than 15. Moreover, the Phe/Tyr ratios at the second and third hour were both significantly higher in patients than in controls. Backwards logistic regression demonstrated the high diagnostic sensitivity and specificity of combined values of neopterin concentration and Phe/Tyr ratio at the second hour. Conclusions. Pterins in urine and Phe loading test are non-invasive and reliable tools for the biochemical diagnosis of GTP-cyclohydrolase deficiency.

Entities:  

Year:  2012        PMID: 23430498      PMCID: PMC3575044          DOI: 10.1007/8904_2012_144

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  39 in total

1.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  Exon deletions in the GCHI gene in two of four Turkish families with dopa-responsive dystonia.

Authors:  C Klein; K Hedrich; K Kabakçi; K Mohrmann; K Wiegers; O Landt; J Hagenah; E Schwinger; P P Pramstaller; L J Ozelius; K Gucuyener; S Aysun; E Demir
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

Review 3.  Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects.

Authors:  G Werner-Felmayer; G Golderer; E R Werner
Journal:  Curr Drug Metab       Date:  2002-04       Impact factor: 3.731

4.  Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene.

Authors:  H Hahn; M R Trant; M J Brownstein; R A Harper; S Milstien; I J Butler
Journal:  Arch Neurol       Date:  2001-05

5.  Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene.

Authors:  Y Furukawa; M Guttman; S P Sparagana; J M Trugman; K Hyland; P Wyatt; A E Lang; G A Rouleau; M Shimadzu; S J Kish
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

6.  The phenylalanine loading test in the differential diagnosis of dystonia.

Authors:  O Bandmann; M Goertz; J Zschocke; G Deuschl; W Jost; H Hefter; U Müller; P Zöfel; G Hoffmann; W Oertel
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

7.  Phenylalanine loading in pediatric patients with dopa-responsive dystonia: revised test protocol and pediatric cutoff values.

Authors:  Thomas Opladen; Jürgen G Okun; Peter Burgard; Nenad Blau; Georg F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2010-07-29       Impact factor: 4.982

8.  Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia.

Authors:  Fabienne Clot; David Grabli; Cécile Cazeneuve; Emmanuel Roze; Pierre Castelnau; Brigitte Chabrol; Pierre Landrieu; Karine Nguyen; Gérard Ponsot; Myriem Abada; Diane Doummar; Philippe Damier; Roger Gil; Stéphane Thobois; Alana J Ward; Michael Hutchinson; Annick Toutain; Fabienne Picard; Agnès Camuzat; Estelle Fedirko; Chankannira Sân; Delphine Bouteiller; Eric LeGuern; Alexandra Durr; Marie Vidailhet; Alexis Brice
Journal:  Brain       Date:  2009-06-02       Impact factor: 13.501

9.  Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome.

Authors:  V Leuzzi; Ca Carducci; Cl Carducci; F Cardona; C Artiola; I Antonozzi
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

10.  Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients.

Authors:  I Trender-Gerhard; M G Sweeney; P Schwingenschuh; P Mir; M J Edwards; A Gerhard; J M Polke; M G Hanna; M B Davis; N W Wood; K P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-03-29       Impact factor: 10.154

View more
  4 in total

1.  Screening for dopa-responsive dystonia in patients with Scans Without Evidence of Dopaminergic Deficiency (SWEDD).

Authors:  Anna De Rosa; Claudia Carducci; Carla Carducci; Silvio Peluso; Maria Lieto; Andrea Mazzella; Francesco Saccà; Vincenzo Brescia Morra; Sabina Pappatà; Vincenzo Leuzzi; Giuseppe De Michele
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

2.  Recessive GCH1 Deficiency Causing DOPA-Responsive Dystonia Diagnosed by Reported Negative Exome.

Authors:  Seth I Berger; Ilana Miller; Laura Tochen
Journal:  Pediatrics       Date:  2022-02-01       Impact factor: 7.124

Review 3.  Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies.

Authors:  Thomas Opladen; Eduardo López-Laso; Elisenda Cortès-Saladelafont; Toni S Pearson; H Serap Sivri; Yilmaz Yildiz; Birgit Assmann; Manju A Kurian; Vincenzo Leuzzi; Simon Heales; Simon Pope; Francesco Porta; Angeles García-Cazorla; Tomáš Honzík; Roser Pons; Luc Regal; Helly Goez; Rafael Artuch; Georg F Hoffmann; Gabriella Horvath; Beat Thöny; Sabine Scholl-Bürgi; Alberto Burlina; Marcel M Verbeek; Mario Mastrangelo; Jennifer Friedman; Tessa Wassenberg; Kathrin Jeltsch; Jan Kulhánek; Oya Kuseyri Hübschmann
Journal:  Orphanet J Rare Dis       Date:  2020-05-26       Impact factor: 4.123

4.  Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Authors:  Niccolò E Mencacci; Ioannis U Isaias; Martin M Reich; Christos Ganos; Vincent Plagnol; James M Polke; Jose Bras; Joshua Hersheson; Maria Stamelou; Alan M Pittman; Alastair J Noyce; Kin Y Mok; Thomas Opladen; Erdmute Kunstmann; Sybille Hodecker; Alexander Münchau; Jens Volkmann; Samuel Samnick; Katie Sidle; Tina Nanji; Mary G Sweeney; Henry Houlden; Amit Batla; Anna L Zecchinelli; Gianni Pezzoli; Giorgio Marotta; Andrew Lees; Paulo Alegria; Paul Krack; Florence Cormier-Dequaire; Suzanne Lesage; Alexis Brice; Peter Heutink; Thomas Gasser; Steven J Lubbe; Huw R Morris; Pille Taba; Sulev Koks; Elisa Majounie; J Raphael Gibbs; Andrew Singleton; John Hardy; Stephan Klebe; Kailash P Bhatia; Nicholas W Wood
Journal:  Brain       Date:  2014-07-02       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.